Figure 5.Effects of fisetin on dual-specificity phosphatase 1 regulation in VSMCs. Representative Western blots and normalized phospho-DUSP1 and total DUSP1 protein abundance (n=6) in HAoSMCs treated for 30 min with control (CTR) or 1 μM fisetin (Fis). *(p<0.05) significant vs. control group.
